RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA to weigh easing limits on unproven peptides BPC 157 Benefits, Dosage & Before After Results The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be